From Randomized Trials to Real-World Data: The Evolution of Outcomes Research and the Path Forward
1,190 words, 6 minutes read time. Marc Berger Marc L. Berger, MD, is a semi-retired, part-time consultant and scientific advisor. Until July 2017, he was Vice President, Real World Data and Analytics at Pfizer, Inc. Marc has held senior-level positions in industry including Executive Vice President and Senior Scientist at OptumInsight; Vice President, Global Health…
Call for Article Submissions: Special Issue on Advances in Biomedical Analytics
Issue: “Advances in Biomedical Analytics: Real-World Evidence, Digital Health, Robotics and Artificial Intelligence” The journal Bioengineering is inviting article submissions for a special issue titled “Advances in Biomedical Analytics: Real-World Evidence, Digital Health, Robotics, and Artificial Intelligence,” focusing on biosignal processing. This issue will be co-edited by leading experts, including Dr. Kelly H. Zou, Founder…
